TLON.OB Insider Trading Activity and SEC Form 4 Filings
TLON.OB insider trading summary
No open-market insider purchases or sales of Talon Therapeutics, Inc. (TLON.OB) have been reported on SEC Form 4 in the past 12 months.
Latest TLON.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 16, 2013 | Deerfield Special Situations Fund, L.P. | 10% Owner | Sell | $91K (1,619,176 @ $0.06) |
| Jul 16, 2013 | Deerfield Private Design Fund L P | 10% Owner | Sell | $91K (1,619,176 @ $0.06) |
| Jul 16, 2013 | James E Flynn | Director | Sell | $91K (1,619,176 @ $0.06) |
| Jul 16, 2013 | Deerfield Private Design International, L.P. | 10% Owner | Sell | $91K (1,619,176 @ $0.06) |
| Jul 16, 2013 | Deerfield Management Co | 10% Owner | Sell | $91K (1,619,176 @ $0.06) |
| Jul 16, 2013 | Deerfield Special Situations Fund International LTD | 10% Owner | Sell | $91K (1,619,176 @ $0.06) |
| Jul 16, 2013 | Deerfield Management Co | 10% Owner | Sell | $167K (2,974,566 @ $0.06) |
| Jul 16, 2013 | Deerfield Special Situations Fund, L.P. | 10% Owner | Sell | $167K (2,974,566 @ $0.06) |
| Jul 16, 2013 | James E Flynn | Director | Sell | $167K (2,974,566 @ $0.06) |
| Jul 16, 2013 | Deerfield Mgmt L.P. | 10% Owner | Sell | $91K (1,619,176 @ $0.06) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.